company_id,name,ticker,legal_name,incorporation_date,sector,sub_sector,industry_classification,hq_city,hq_state,hq_country,regions_operated,founder_names,founding_story_summary,mission_statement,ownership_status,listed_exchange,isin,cik_like,lei_like,fiscal_year_end,employees_2020,employees_2021,employees_2022,employees_2023,employees_2024,employees_2025_ytd,union_presence_pct_2024,remote_work_pct_2024,primary_products,primary_services,core_ip_assets,patent_count_2025,subsidiaries,banking_partners,major_customers,major_suppliers,go_to_market_strategy,pricing_model,primary_cloud_provider,erp_system,crm_system,data_stack,security_certifications,environmental_goals,diversity_goals,esg_policy_summary,risk_register_top3,competitors,regulators,accounting_standard,tax_jurisdictions,transfer_pricing_method,credit_rating_internal,cash_management_policy,treasury_risk_limits,board_size,board_committees,board_independence_pct_2024,auditor,legal_counsel,pr_agency,investor_relations_contact,media_contact,careers_url_placeholder,website_placeholder,status
C008,NeuraGen AI,NGAI,"NeuraGen Artificial Intelligence Solutions Ltd",2016-08-09,"Artificial Intelligence","AI-Driven Healthcare Analytics","NAICS 541715; SIC 8734; GICS 45201020",London,N/A,UK,"Europe; North America; Asia-Pacific","Dr. Solene Martin; Isaac Reyes","Founded from UCL AI research to enable real-time diagnostic analytics and predictive models in healthcare combining machine learning with clinical workflows for better patient outcomes.","To empower clinicians through transparent, actionable AI insights that improve patient outcomes and operational efficiencies.","Private",N/A,N/A,0008901234,549300NUAI453202,"December 31",410,580,750,910,1100,1220,11,74,"NeuraDiagnose Platform; PredictCare AI Suite; NeuroGenomics Insights","Clinical analytics; predictive modelling; operational workflow optimization","Deep learning diagnostic pipelines; genomic data integration;AI explainability layers",53,"NeuraGen GmbH (Berlin); NeuraGen US Inc.","Royal Bank of Scotland; Wells Fargo","NHS Trusts; Mayo Clinic; Genentech; Medisafe Health","NVIDIA; Intel AI Labs; Cobalt CyberGuard (C004) security","Direct sales to health systems; partnership with Medisafe and TechForge; academic collaborations","Subscription seat-based pricing + volume data fees; implementation charges","AWS with GCP backup for compliance and research","Oracle ERP","Microsoft Dynamics CRM","Snowflake; Databricks; TensorFlow; Kafka","ISO 13485; ISO 27001; HIPAA; FDA AI Software Pre-cert","Carbon-neutral by 2032; 80% renewable energy by 2026; zero single-use plastics","48% women/non-binary leadership by 2028; inclusive hiring policies; accessibility initiatives","ESG program centers on patient privacy, equitable AI, sustainable operations, and transparent governance.","1. Clinical validation risk; 2. Regulatory approval delays; 3. Data privacy compliance risk","IBM Watson Health; Google DeepMind Health; PathAI; Veracyte","MHRA UK; FDA US; EMA EU","IFRS","UK; USA; EU","Transactional Net Margin Method","A- (stable), internal rating","Maintain 10 months liquidity buffer; 55% cash in UK gilts; limit vendor exposures","VaR $2M daily; max single asset $8M; FX hedge Â±$0.5M",8,"Audit; Regulatory Compliance; Compensation; ESG; Nominating",62,"Deloitte UK","Wickham & Porter Legal","Brightlight Communications","ir@neuragen-ai.com","media@neuragen-ai.com","https://careers.neuragen-ai.com","https://www.neuragen-ai.com",Active
